How FDA Could Make Prescription Drug Ads Less Annoying

As I wrote earlier this week, prescription drug ads are back on the airwaves in a big way. After ad spending had been declining in recent years, drugmakers in 2014 spent $4.5 billion marketing their products directly to consumers — more than any year previously.

A number of comments I received on that story questioned why the frighteningly long list of possible side effects that frequently accompany the ads are just so long and so frightening. Was this something that the drugmakers weredoing to deflect blame in case something went wrong?

Hey, check out all the research scientist jobs. Post your resume today!

MORE ON THIS TOPIC